We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 25.50 | 2.65% | 987.00 | 973,842 | 16:35:01 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 994.50 | 1,004.00 | 1,013.00 | 958.00 | 1,001.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | USD 1.09B | USD 2M | USD 0.0147 | 673.47 | 1.31B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:35:08 | AT | 900 | 987.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 26/7/2024 | 15:37 | UK RNS | Indivior PLC Director/PDMR Shareholding |
| 26/7/2024 | 15:34 | UK RNS | Indivior PLC Director/PDMR Shareholding |
| 25/7/2024 | 07:10 | UK RNS | Indivior PLC Share Repurchase Program |
| 25/7/2024 | 07:00 | UK RNS | Indivior PLC Half-year Report |
| 23/7/2024 | 07:00 | UK RNS | Indivior PLC Transaction in Own Shares |
| 18/7/2024 | 16:26 | UK RNS | Indivior PLC Holding(s) in Company |
| 16/7/2024 | 07:00 | UK RNS | Indivior PLC Transaction in Own Shares |
| 15/7/2024 | 07:00 | UK RNS | Indivior PLC Notice of Results |
| 12/7/2024 | 07:00 | UK RNS | Indivior PLC Holding(s) in Company |
| 11/7/2024 | 07:00 | UK RNS | Indivior PLC Holding(s) in Company |
Indivior (INDV) Share Charts1 Year Indivior Chart |
|
1 Month Indivior Chart |
Intraday Indivior Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/7/2024 | 22:35 | INDIVIOR THE PILL WITH NO CHEERS OR BEERS | 4,054 |
| 09/3/2020 | 10:34 | RB. de-merger | 548 |
| 11/7/2019 | 08:29 | Johnson & Johnson court case oklahoma | 6 |
| 03/5/2019 | 10:16 | Judgement against insys | 2 |
| 31/7/2018 | 13:45 | Indivior (INDV) IP Battle Status | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 15:35:08 | 987.00 | 900 | 8,883.00 | AT |
| 2024-07-26 15:35:08 | 987.00 | 2,193 | 21,644.91 | AT |
| 2024-07-26 15:35:08 | 987.00 | 1 | 9.87 | AT |
| 2024-07-26 15:35:01 | 987.00 | 366,393 | 3,616,298.91 | UT |
| 2024-07-26 15:34:13 | 979.50 | 198 | 1,939.41 | O |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Indivior Daily Update Indivior Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker INDV. The last closing price for Indivior was 961.50p.Indivior currently has 136,011,398 shares in issue. The market capitalisation of Indivior is £1,346,512,840. Indivior has a price to earnings ratio (PE ratio) of 673.47. This morning INDV shares opened at 1,001p |
Posted at 25/7/2024 07:36 by hunter154 Funny how the $160m provision wasn't mentioned 2 weeks ago.Apart from that, nothing new. Accelerated buy backs should put a floor on the Share Price |
Posted at 24/7/2024 18:35 by casholaa https://www.asktrade |
Posted at 17/7/2024 10:53 by davius Just been giving Indivior a cursory look...Market cap £1bn, bottom end of expected profit £220m, P/E under 5. $100m a year on share buy backs. A poorly received update. I'm missing something significant. Otherwise the share price fall looks well over done. |
Posted at 17/7/2024 08:42 by imjustdandy Overdone now. Gradual recovery of the share price |
Posted at 09/7/2024 18:48 by casholaa I think that the last trade in the US 13:28:03 Traded price approx. US$10.255 = approx. £8.02 (delayed prices as it's about 13:49 now)Ticker should be U-INDV |
Posted at 09/7/2024 13:26 by dealy on the subject of buybacks, the CEO said, "Given the share price" they will "actively assess" the use of cash (which seems to imply they will allocate more cash to buy backs) |
Posted at 09/7/2024 08:53 by ricky46 So on the 23/5 they reconfirm guidance, that was so they got the Nasdaq listing away as smooth as possible, then the share price drifts on a leaky ship, then 7 weeks later they drop all this news, terrible untrustworthy management in my opinion glad I sold out on the drift down, wish everyone the best of luck |
Posted at 09/7/2024 07:16 by la forge Richmond, VA, July 9, 2024 - Indivior PLC (Nasdaq/LSE: INDV) today announces a business update encompassing the Group's outlook for Q2 and FY 2024 financial performance, its product portfolio and litigation. Indivior is:· Updating Q2 net revenue (NR) expectations and FY 2024 guidance to reflect continued adverse market dynamics impacting near-term SUBLOCADE NR growth as well as the initial commercial adoption of OPVEE; At the mid-point, the Group continues to expect strong YOY NR growth for SUBLOCADE of 25% and YOY adjusted operating income growth of 12% in FY 2024; · Reiterating its medium-term financial outlook for double-digit NR growth and operating margin expansion, based on its confidence in achieving its intermediate and peak NR goals for SUBLOCADE as well as peak NR expectations for OPVEE; · Discontinuing sales and marketing for PERSERIS due to expected adverse impacts from increased payor management of the category that crystalized in Q2 and that are expected to make the product no longer financially viable; and, · Reaching a settlement agreement with end payor plaintiffs in the Health Care Services Corp (HCSC) consolidated cases to resolve the litigation for $85m. |
Posted at 04/7/2024 08:35 by swinsco "Indivior CEO Expects Ongoing U.S. Opioid Crisis to Drive Sales Growth"WSJ business news article out after hours yesterday. It's behind a paywall but the headline gives the right impression. Nasdaq share price recovered and finished flat yesterday which is showing up in today's opening price. |
Posted at 12/3/2022 17:05 by typo56 The news is quite possibly a continuation of this from 23 Feb.."Indivior, the FTSE 250-listed opiod addiction treatment company, is rumoured to be the mystery bidder circling Opiant Pharmaceuticals, the US-listed developer of medicines for drug addiction. People following the situation have heard rumours Indivior has been talking to Opiant since December last year year about a possible offer for the company." Good or bad for the INDV share price? You decide! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
